Clinical Outcomes Research

About AliveCor

AliveCor is a pioneer and leader in the consumer-facing personal electrocardiogram (EKG) market, founded in 2011. The company's core product line, Kardia, includes several FDA-cleared, portable devices that record medical-grade EKGs which are analyzed via a smartphone app for arrhythmias like atrial fibrillation (AFib). AliveCor has built a significant installed base, recording over 300 million EKGs globally, and has expanded its business model to include a recurring revenue subscription service (KardiaCare) offering advanced analytics and telehealth support. The company operates as a private entity, competing directly with large consumer electronics and wearable companies while navigating a complex regulatory and reimbursement landscape.

Therapeutic Areas